Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Predictive Oncology Inc. Director's Dealing 2025

Oct 17, 2025

35106_dirs_2025-10-17_77ab67c0-2e69-46a2-b03b-cd87bef9c190.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Predictive Oncology Inc. (POAI)
CIK: 0001446159
Period of Report: 2025-10-08

Reporting Person: McLaughlin Thomas Louis (Chief Investment Officer)

More from Predictive Oncology Inc.

Regulatory Filings 2026
May 15
Regulatory Filings 2026
May 15
Regulatory Filings 2026
May 15
Interim / Quarterly Report 2026
May 15
Regulatory Filings 2026
May 12
Regulatory Filings 2026
Apr 22
Regulatory Filings 2026
Apr 16
Regulatory Filings 2026
Apr 1
Director's Dealing 2026
Feb 10
Regulatory Filings 2026
Feb 9
View all filings →